FLVCR1
protein-codingFLVCR heme transporter 1, the group of Solute carrier family 49
Gene summary
This gene encodes a member of the major facilitator superfamily of transporter proteins. The encoded protein is a heme transporter that may play a critical role in erythropoiesis by protecting developing erythroid cells from heme toxicity. This gene may play a role in posterior column ataxia with retinitis pigmentosa and the hematological disorder Diamond-Blackfan syndrome. [provided by RefSeq, Jan 2011]
- AXPC1
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~41.1 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0100449
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0012177
Submitter: Illumina
The FLVCR1 gene is located on chromosome 1 at 1q32.3 and encodes the FLVCR heme transporter 1 protein, a member of the major facilitator superfamily of transporter proteins which is specifically involved in the transmembrane transport of cytoplasmic heme. The protein plays a critical role in erythropoiesis by protecting the developing erythroid cells from heme toxicity. FLVCR1 was first reported in relation to autosomal recesssive posterior column ataxia-retinitis pigmentosa syndrome in 2010 (21070897: Rajadhyaksha et al. 2010). At least 11 unique variants (including missense and loss of function variants) have been reported in humans. Evidence supporting this gene-disease relationship includes case-level data, segregation data and experimental evidence. Variants in this gene have been reported in at least seven probands in three publications (27923065: Chiabrando et al. 2016; 27353947: Tiwari et al. 2016; 30656474: Kuehlewein et al. 2019). Variants in this gene segregated with disease in two families. Clinical variability was noted with affected individuals presenting with either posterior column ataxia with retinitis pigmentosa (PCARP), non-syndromic retinitis pigmentosa, or hereditary sensory and autonomic neuropathy (HSAN). More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. It is suggested that the underlying disease mechanism may be heme overload (27923065: Chiabrando et al. 2016). This gene-disease relationship is supported by expression studies and in vitro functional assays in patient and non-patient cells (21070897: Rajadhyaksha et al. 2010; 27923065: Chiabrando et al. 2016). In summary, FLVCR1 is definitively associated with autosomal recessive posterior column ataxia-retinitis pigmentosa syndrome.
Inheritance Pattern: AR
Disease ID:MONDO:0012177
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0100449
Submitter: ClinGen
FLVCR1 was first reported in relation to autosomal recessive FLVCR1-related retinopathy with or without ataxia (also known as posterior column ataxia-retinitis pigmentosa syndrome; PCARP) in 2010 (Rajadhyaksha et al., PMID: 21070897). This condition is characterized by childhood onset retinal dystrophy and progressive sensory ataxia. At least 321 variants (e.g. missense, in-frame indel, nonsense, frameshift, large deletion, complex rearrangement, etc) have been reported in humans (ClinVar database). Evidence supporting this gene-disease relationship includes case-level data, segregation data, and experimental data. This curation includes 12 variants (missense, frameshift, nonsense, intronic) from 11 probands from 5 publications (Rajadhyaksha et al, 2010, PMID: 21070897; Ishiura et al, 2011, PMID: 21267618; Castori et al, 2017, PMID: 28766925; Kuehlewein et al, 2019, PMID 30656474; Grudzinska Pechhacker et al, 2020, PMID: 32822874) in addition to segregation data (Rajadhyaksha et al, 2010, PMID: 21070897). More data is available in the literature but the maximum score for genetic evidence (12 points) has been reached. Experimental evidence included qPCR expression data in mice (Rajadhyaksha et al, 2010, PMID: 21070897), functional studies in patient cells, and a homology model of the protein (Grudzinska Pechhacker et al, 2020, PMID: 32822874). In summary, FLVCR1 has a definitive relationship with FLVCR1-related retinopathy with or without ataxia. This classification was approved by the ClinGen Retina GCEP on August 5, 2021.
Inheritance Pattern: AR
Disease ID:MONDO:0012177
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0012177
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Hematologic; Neurologic; Ophthalmologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to FLVCR1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_014053.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 18 | 122 | 141 | ||
| missense | 6 | 17 | 228 | 7 | 258 | |
| nonsense | 4 | 9 | 13 | |||
| start loss | 1 | 2 | 3 | |||
| frameshift | 14 | 15 | 4 | 33 | ||
| splice donor/acceptor (+/-2bp) | 1 | 3 | 2 | 6 | ||
| Total | 26 | 47 | 252 | 129 | 0 | 454 |
Highest pathogenic variant AF is 0.00034900446
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_054772.1 | 10 | MANE Select | |
| Ensembl | ENSP00000355938.4 | 10 | MANE Select | |
| Ensembl | ENSP00000414680.1 | 9 | Standard | |
| Ensembl | ENSP00000537672.1 | 11 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| flvcr1 | Danio rerio | Structure: nucleate erythrocyte Quality: decreased amount abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Transport of small molecules
- Iron uptake and transport
Biological Process
- blood vessel development
- in utero embryonic development
- mitochondrial transport
- cellular iron ion homeostasis
- multicellular organism development
Molecular Function
- transporter activity
- protein binding
- heme transporter activity
- heme binding
Cellular Component
- mitochondrion
- plasma membrane
- integral component of plasma membrane
- mitochondrial membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000366971
- Coding exons
- 10
- Length
- 41109
- Individuals with no LoFs
- 125704
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 44
- Defined
- 125748
- p
- 0.000175
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.852 | 243 | 283 | 0.858 | 0.0000130 | 3516 |
| Missense (PolyPhen) | 50 | 69.436 | 0.72009 | 880 | ||
| Synonymous | -0.193 | 119 | 116 | 1.02 | 0.00000567 | 1181 |
| Loss of Function | 2.77 | 9 | 23.5 | 0.383 | 0.00000108 | 292 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00025 | 0.00025 | rare |
| Latino/Admixed American | 0.00020 | 0.00020 | rare |
| Ashkenazi Jewish | 0.000099 | 0.000099 | rare |
| East Asian | 0.00011 | 0.00011 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00020 | 0.00020 | rare |
| South Asian | 0.00020 | 0.00020 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Isoform 1: Heme transporter that exports cytoplasmic heme. It can also export coproporphyrin and protoporphyrin IX, which are both intermediate products in the heme biosynthetic pathway. Does not export bilirubin. Heme export depends on the presence of HPX and is required to maintain intracellular free heme balance, protecting cells from heme toxicity. Heme export provides protection from heme or ferrous iron toxicities in liver, brain, sensory neurons and during erythtopoiesis, a process in which heme synthesis intensifies. Causes susceptibility to FeLV-C in vitro. {ECO:0000269|PubMed:10400745, ECO:0000269|PubMed:15369674, ECO:0000269|PubMed:20610401, ECO:0000269|PubMed:27923065}.;
- Disease
- DISEASE: Posterior column ataxia with retinitis pigmentosa (PCARP) [MIM:609033]: A neurodegenerative syndrome beginning in infancy with areflexia and retinitis pigmentosa. Nyctalopia (night blindness) and peripheral visual field loss are usually evident during late childhood or teenage years, with subsequent progressive constriction of the visual fields and loss of central retinal function over time. A sensory ataxia caused by degeneration of the posterior columns of the spinal cord results in a loss of proprioceptive sensation that is clinically evident in the second decade of life and gradually progresses. Scoliosis, camptodactyly, achalasia, gastrointestinal dysmotility, and a sensory peripheral neuropathy are variable features of the disease. Affected individuals have no clinical or radiological evidence of cerebral or cerebellar involvement. {ECO:0000269|PubMed:21070897, ECO:0000269|PubMed:21267618}. Note=The disease is caused by mutations affecting the gene represented in this entry. Defective neuronal heme transmembrane export due to FLVCR1 mutations may abrogate the neuroprotective effects of neuroglobin and initiate an apoptotic cascade that results in the selective degeneration of photoreceptors in the neurosensory retina and sensory neurons in the posterior spinal cord.; DISEASE: Note=Defects in FLVCR1 are a cause of a sensory neuropathy resulting in pain insensitivity. Patients have decreased sensing of pain, temperature and touch. Self-injury, ulcers and amputations are commonly observed in affected individuals. {ECO:0000269|PubMed:27923065}.;
Recessive Scores
- pRec
- 0.112
Intolerance Scores
- LoFtool
- 0.465
- RVIS EVS
- 0.02
- RVIS percentile EVS
- 55.45
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- K
- Indispensability pred.
- E
- Indispensability score
- 0.650
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | High |
| Cancer | Medium | Medium | Medium |